Green Cross Lab Cell Corporation (144510) - Total Liabilities

Latest as of September 2025: ₩134.23 Billion KRW ≈ $90.97 Million USD

Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has total liabilities worth ₩134.23 Billion KRW (≈ $90.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Green Cross Lab Cell Corporation to assess how effectively this company generates cash.

Green Cross Lab Cell Corporation - Total Liabilities Trend (2015–2024)

This chart illustrates how Green Cross Lab Cell Corporation's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Green Cross Lab Cell Corporation to evaluate the company's liquid asset resilience ratio.

Green Cross Lab Cell Corporation Competitors by Total Liabilities

The table below lists competitors of Green Cross Lab Cell Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
DCX Systems Limited NSE:DCXINDIA	India	Rs6.45 Billion
Mitrabahtera Segara Sejati Tbk JK:MBSS	Indonesia	Rp23.93 Million
Vine Hill Capital Investment Corp. Class A Ordinary Shares NASDAQ:VCIC	USA	$234.54 Million
Roman DBDR Acquisition Corp. II Ordinary shares NASDAQ:DRDB	USA	$1.10 Million
Supermax Corporation Bhd KLSE:7106	Malaysia	RM343.10 Million
Nam Viet Corp VN:ANV	Vietnam	₫2.30 Trillion
Victoria Care Indonesia Tbk Pt JK:VICI	Indonesia	Rp239.77 Billion
Nusantara Infrastructure Tbk JK:META	Indonesia	Rp640.04 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Green Cross Lab Cell Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Green Cross Lab Cell Corporation market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Green Cross Lab Cell Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Green Cross Lab Cell Corporation (2015–2024)

The table below shows the annual total liabilities of Green Cross Lab Cell Corporation from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩120.56 Billion ≈ $81.70 Million	-2.53%
2023-12-31	₩123.69 Billion ≈ $83.82 Million	-10.42%
2022-12-31	₩138.07 Billion ≈ $93.57 Million	+2.60%
2021-12-31	₩134.57 Billion ≈ $91.20 Million	+360.97%
2020-12-31	₩29.19 Billion ≈ $19.78 Million	+21.56%
2019-12-31	₩24.02 Billion ≈ $16.27 Million	+151.56%
2018-12-31	₩9.55 Billion ≈ $6.47 Million	+35.76%
2017-12-31	₩7.03 Billion ≈ $4.77 Million	+9.59%
2016-12-31	₩6.42 Billion ≈ $4.35 Million	-18.81%
2015-12-31	₩7.90 Billion ≈ $5.36 Million	--

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$241.86 Million

₩356.89 Billion KRW

Market Cap Rank

#15826 Global

#627 in Korea

Share Price

₩23750.00

Change (1 day)

-2.66%

52-Week Range

₩18280.00 - ₩27500.00

All Time High

₩126167.70